We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.97%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.3B
AUM Growth
+$1.17B
(+4.5%)
Cap. Flow
-$1B
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
13.33%
Holding
1,440
New
99
Increased
518
Reduced
438
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$58.6M |
| 2 |
Charter Communications
CHTR
|
+$45.8M |
| 3 |
Credit Acceptance
CACC
|
+$44.9M |
| 4 |
Home Depot
HD
|
+$43M |
| 5 |
Autodesk
ADSK
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$77.5M |
| 2 |
Apple
AAPL
|
+$73.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$64.7M |
| 4 |
Merck
MRK
|
+$58.9M |
| 5 |
Qualcomm
QCOM
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 11.41% |
| 4 | Consumer Discretionary | 10.23% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Bloomin' Brands
BLMN
$686M
| $8.53M | 0.03% |
431,200
-43,100
| -9% | -$842K |
|
502
Neurocrine Biosciences
NBIX
$15.2B
| $8.46M | 0.03% |
68,822
-14,730
| -18% | -$1.67M |
|
503
Broadridge
BR
$19.4B
| $8.46M | 0.03% |
64,104
+13,900
| +28% | +$1.76M |
|
|
GWPH
504
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $8.4M | 0.03% |
48,644
-10,662
| -18% | -$1.54M |
|
505
G-III Apparel Group
GIII
$1.19B
| $8.38M | 0.03% |
173,813
+60,300
| +53% | +$2.74M |
|
506
Marathon Petroleum
MPC
$115B
| $8.31M | 0.03% |
103,973
+47,084
| +83% | +$3.72M |
|
507
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $8.26M | 0.03% |
190,900
| – | – |
|
508
argenx
ARGX
$61.3B
| $8.18M | 0.03% |
107,906
| – | – |
|
509
Crown Castle
CCI
$31.2B
| $8.17M | 0.03% |
73,416
-380
| -0.5% | -$42.3K |
|
510
Nutrien
NTR
$37.6B
| $8.13M | 0.03% |
140,924
+449
| +0.3% | +$24.9K |
|
|
STAY
511
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $8.09M | 0.03% |
399,900
-202,500
| -34% | -$4.21M |
|
512
Celanese
CE
$5.18B
| $8.07M | 0.03% |
70,794
| – | – |
|
|
PE
513
DELISTED
PARSLEY ENERGY INC
PE
| $8.02M | 0.03% |
274,306
-6,310
| -2% | -$187K |
|
514
iShares Core US Aggregate Bond ETF
AGG
$137B
| $8.01M | 0.03% |
75,930
+17,770
| +31% | +$1.88M |
|
515
Marriott International
MAR
$87.9B
| $7.99M | 0.03% |
60,509
-4,324
| -7% | -$552K |
|
516
Fox Factory Holding Corp
FOXF
$805M
| $7.89M | 0.03% |
112,690
-4,040
| -3% | -$247K |
|
517
CoreCivic
CXW
$3.5B
| $7.88M | 0.03% |
323,904
-45,800
| -12% | -$1.14M |
|
|
CLDR
518
DELISTED
Cloudera, Inc.
CLDR
| $7.88M | 0.03% |
446,387
-22,258
| -5% | -$338K |
|
519
Jabil
JBL
$31B
| $7.88M | 0.03% |
290,800
-4,200
| -1% | -$120K |
|
|
FOMX
520
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $7.85M | 0.03% |
1,369,341
+416,787
| +44% | +$2.38M |
|
|
BIG
521
DELISTED
Big Lots, Inc.
BIG
| $7.84M | 0.03% |
187,700
-15,700
| -8% | -$693K |
|
522
Halozyme
HALO
$12.1B
| $7.78M | 0.03% |
428,217
+37,108
| +9% | +$650K |
|
523
SITE Centers
SITC
$150M
| $7.77M | 0.03% |
744,158
-153,794
| -17% | -$1.68M |
|
|
EXAS
524
DELISTED
Exact Sciences
EXAS
| $7.77M | 0.03% |
98,400
+75,642
| +332% | +$4.93M |
|
525
Credicorp
BAP
$29.6B
| $7.76M | 0.03% |
34,805
+166
| +0.5% | +$37.1K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2018 Portfolio in Review
As of Q3 2018, Axa held 1,440 positions worth $27.3B, up 4.5% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Axa withdrew a net $1B in Q3 2018, closing 115 positions and reducing 438 holdings. Its most notable exit was CA, Inc., an estimated $56.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in KKR & Co worth $27.3M.
- Axa's largest Q3 2018 buy was KKR & Co: 1,000,000 shares worth $27.3M.
- Axa added most to Intel in Q3 2018, an estimated $58.6M increase.
- Axa's biggest Q3 2018 reduction was DexCom, cutting an estimated $77.5M.
- Axa fully exited CA, Inc. in Q3 2018, selling an estimated $56.1M.
- Axa's ten largest holdings make up 13% of its $27.3B portfolio in Q3 2018.
- Axa opened 99 new positions and closed 115 in Q3 2018.
- Axa's portfolio value rose 4.5% quarter-over-quarter to $27.3B.
Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.